中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

文献类型:期刊论文

作者Zhang,Tao1; Qu,Rong1; Chan,Shingpan2; Lai,Mengzhen1,3; Tong,Linjiang1; Feng,Fang1; Chen,Hongyu4; Song,Tingting4; Song,Peiran1; Bai,Gang1,5,6
刊名Molecular Cancer
出版日期2021-08-17
卷号20期号:1
DOI10.1186/s12943-021-01391-x
通讯作者Ding,Ke(dingke@jnu.edu.cn) ; Ding,Jian(jding@simm.ac.cn) ; Xie,Hua(hxie@simm.ac.cn)
语种英语
出版者BioMed Central
WOS记录号BMC:10.1186/S12943-021-01391-X
源URL[http://119.78.100.183/handle/2S10ELR8/297582]  
专题新药研究国家重点实验室
通讯作者Ding,Ke; Ding,Jian; Xie,Hua
作者单位1.Shanghai Institute of Materia Medica, Chinese Academy of Sciences; Division of Antitumor Pharmacology, State Key Laboratory of Drug Research
2.Jinan University; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemistry Drug Development, School of Pharmacy
3.Fudan University; School of Pharmacy
4.Jiangsu Aosaikang Pharmaceutical Co.Ltd (ASK pharm)
5.University of Chinese Academy of Sciences
6.ShanghaiTech University; School of Life Science and Technology
推荐引用方式
GB/T 7714
Zhang,Tao,Qu,Rong,Chan,Shingpan,et al. Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance[J]. Molecular Cancer,2021,20(1).
APA Zhang,Tao.,Qu,Rong.,Chan,Shingpan.,Lai,Mengzhen.,Tong,Linjiang.,...&Xie,Hua.(2021).Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.Molecular Cancer,20(1).
MLA Zhang,Tao,et al."Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance".Molecular Cancer 20.1(2021).

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。